Search result for 'glp-1 peptide'

Biocon launches Liraglutide, a GLP-1 peptide, in the UK for diabetes and obesity management. This marks the first generic approval for gLiraglutide in a major market.

Biocon and South Korea's Handok have signed a licensing and supply agreement for Biocon's Liraglutide, used in chronic weight management, to be commercialized in South Korea.